Merging Regulatory and Reimbursement Needs in Clinical Trials

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.02.007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

White Paper AGA: Gastroparesis: Clinical and Regulatory Insights for Clinical Trials

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2017English

Maintaining Electronic Regulatory Binder at Clinical Trials Site Improves Efficiency

International Journal of Clinical Trials
2019English

Draft Guidance on Clinical Trials Recognises Needs of Non-Commercial Research

BMJ
2004English

Patient-Reported Outcomes in Clinical Trials of Inhaled Asthma Medications: Systematic Review and Research Needs

Quality of Life Research
EnvironmentalPublic HealthOccupational Health
2010English

Lessons for Adaptive Licensing: Analysis of Conditionally Approved EMA Compounds, Their Reimbursement Status and Regulatory/Reimbursement Data Requirements

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Incorporating and Interpreting Regulatory Guidance on Estimands in Diabetes Clinical Trials: The PIONEER 1 Randomized Clinical Trial as an Example

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

OARSI Clinical Trials Recommendations: Hip Imaging in Clinical Trials in Osteoarthritis

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2015English

Translating Mechanism of Regulatory Action of Tolerogenic Dendritic Cells to Monitoring Endpoints in Clinical Trials

Frontiers in Immunology
AllergyImmunology
2017English

The Conduct of Clinical Trials for Medicinal Products in Europe in the Light of the European Clinical Trials Directive. Review of Regulatory and Practical Aspects in the Different Countries

Therapie
Pharmacology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy